John Mascarenhas, MD | Authors

Articles

Review of the PERSIST-1 and PERSIST-2 Trials

April 20, 2022

John Mascarenhas, MD, describes his personal experience with using pacritinib to treat patients with myelofibrosis and reviews the study design and outcomes for both the PERSIST-1 and PERSIST-2 trials.